Prediction: Lilly Will Reach $1,200 in 2026 — Investment Thesis
Eli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Which passive funds are cheap for retirement? Focus on low-fee, diversified funds to maximize long-term growth with predictable costs.
23,256 articlesEli Lilly’s GLP-1 drugs are redefining growth in obesity and diabetes treatment. This article lays out why the stock ...
Turnaround stories can create powerful upside for patient investors, but they also open doors for short sellers who b...
Geopolitical tension in the Middle East sparked a swift crypto reaction, with Bitcoin swinging as officials weigh a p...
A surge in Palo Alto Networks stock in May grabbed headlines, but a reverse move in June left investors weighing the ...
Last month, poet technologies skyrocketed 72.6%, delivering a dramatic rally in a volatile sector. This article expla...
As AI workloads push memory demand higher, micron stock could have substantial upside. Yet a high-capex Virginia expa...
Oracle enters a critical earnings season with eyes on its AI pivot and data-center expansion. The market has piled on...
Asset managers reevaluating security are treating safety features as a core lever to stabilize NOI and attract tenant...
A security researcher leveraged Claude-powered tooling to reveal a long-standing vulnerability in Zcash's Orchard cir...
A low-cost $4 treatment is gaining traction as a flesh-eating screwworm reemerges in U.S. livestock. Ranchers and vet...
The 2026 World Cup doubles as a proving ground for AI deployments from Big Tech. From AI-enabled devices to officiati...
Lee’s Bitmine moved to grow its ETH treasury with a $41 million purchase, signaling a continued expansion strategy ev...